ProGnosis Biotech is proud to become a member of Campden BRI, a global leader for the
food and drink industry, with over 4000 member companies in more than 90 countries.
Many of their technical services are accredited in accordance with the recognized
International Standard ISO17025:2017 by the United Kingdom Accreditation Service (UKAS).
This membership represents a significant step in our commitment to advancing food safety
and quality assurance.
Joining the Campden BRI community offers access to their world-class expertise in result
interpretations, sample handling, accredited methods, proficiency testing and regulatory
controls, allowing ProGnosis Biotech to continue to stay at the forefront of food safety
innovation. This collaboration enables us to enhance our ability to meet food safety
challenges and further develop reliable testing solutions for our clients across the supply
chain.
We look forward to utilizing Campden BRI’s resources and expertise to continue innovating in
food safety, ensuring the highest standards of product integrity, in both science and service.
ProGnosis Biotech Rapid Tests Featured at Pneumonology DaysConference
The annual Panhellenic Pneumonology Conference of the University of Thessaly, named Pneumonology Days, took place from October 10 to October 13 at the university’s Medical
October 15, 2024
